| Chad Blake Carlson, MD | |
|
310 N 9th St, Bismarck, ND 58501-4515 | |
| (701) 530-8800 | |
| (701) 751-4550 |
| Full Name | Chad Blake Carlson |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 310 N 9th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588873186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 11836 (North Dakota) | Primary |
| Entity Name | Bismarck Surgical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1255339628 PECOS PAC ID: 6800855099 Enrollment ID: O20080327000049 |
News Archive
The World Health Organization estimates that in 2011 there were 216 million cases of malaria and 34.2 million people living with HIV. These diseases particularly afflict sub-Saharan Africa, where large incidence of co-infection result in high mortality rates. Yet, in spite of this global pandemic, interactions between the parasite that causes malaria, Plasmodium falciparum, and HIV-1 are poorly understood.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is the subject of a new research report issued by Emerging Growth Research, LLP.
Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.
The agreement sets up a powerful mechanism for agreement on tax reforms to strengthen growth, and entitlement reforms to strengthen programs such as Medicare. A congressional committee with fast-track authority will have a Nov. 23 deadline to recommend a balanced package of long-term reforms to produce $1.5 trillion in additional deficit reduction.
"More than 50 percent of all new cancers and two-thirds of the annual cancer mortality worldwide happen in low-income and middle-income countries," a Lancet editorial states and describes how the recently released report Closing the Cancer Divide, by the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, "presents a compelling case for comprehensive action on expanded access to cancer care and control with realistic recommendations that will be beneficial beyond cancer."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chad Blake Carlson, MD 310 N 9th St, Bismarck, ND 58501-4515 Ph: (701) 530-8800 | Chad Blake Carlson, MD 310 N 9th St, Bismarck, ND 58501-4515 Ph: (701) 530-8800 |
News Archive
The World Health Organization estimates that in 2011 there were 216 million cases of malaria and 34.2 million people living with HIV. These diseases particularly afflict sub-Saharan Africa, where large incidence of co-infection result in high mortality rates. Yet, in spite of this global pandemic, interactions between the parasite that causes malaria, Plasmodium falciparum, and HIV-1 are poorly understood.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is the subject of a new research report issued by Emerging Growth Research, LLP.
Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.
The agreement sets up a powerful mechanism for agreement on tax reforms to strengthen growth, and entitlement reforms to strengthen programs such as Medicare. A congressional committee with fast-track authority will have a Nov. 23 deadline to recommend a balanced package of long-term reforms to produce $1.5 trillion in additional deficit reduction.
"More than 50 percent of all new cancers and two-thirds of the annual cancer mortality worldwide happen in low-income and middle-income countries," a Lancet editorial states and describes how the recently released report Closing the Cancer Divide, by the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, "presents a compelling case for comprehensive action on expanded access to cancer care and control with realistic recommendations that will be beneficial beyond cancer."
› Verified 8 days ago
Dr. Joseph W Carlson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 N 9th St, Bismarck, ND 58501 Phone: 701-530-8800 Fax: 701-530-8763 | |
Dr. Timothy J Bopp, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 N 9th St, Bismarck, ND 58501 Phone: 701-530-8800 Fax: 701-583-0876 | |
Ian C Fyfe, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5823 | |
Dr. Timothy J Juelson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 N 9th St, Bismarck, ND 58501 Phone: 701-530-8800 Fax: 701-751-4550 | |
Coridon Michael Huez, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-8920 Fax: 701-323-5849 | |
William D Canham, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5823 | |
Anthony Robert Kasch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-8920 |